2nd Clinical Site for Gene Therapy Trial for Usher Syndrome
July 26, 2012
Submit Comments
The Foundation Fighting Blindness and Oxford BioMedica announced funding for a second clinical site to conduct a gene therapy trial for Ushers Syndrome. The site will be the Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts in Paris, and will join the ongoing clinical trial being held at the Oregon Health & Science University’s Casey Eye Institute.
To read all of the details, please follow this link.
Comments (0)
Trackbacks
Print this post
Filed in Clinical Trials, Macular Degeneration, NeuroOphthalmology, New Technologies, Research, Retina
You might also enjoy...
- Gene Therapy Trial for Retinitis Pigmentosa Based on Usher’s Syndrome To Begin
- Stem Cells Inc. Gets FDA Authorization to Initiate Clinical Trial to Use Human Neural Stem Cells to Treat Dry AMD
- ACT Adds Third Clinical Trial Site for Testing Treatment of Dry Macular Degeneration With Embryonic Stem Cells
- A Complete List of Current Ophthalmic Stem Cell Trials
- Can Gene Therapy Help Treat Usher Syndrome Patients with Retinitis Pigmentosa?
Comments
Jump down to form below to submit your own comments
